How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

At the AIG Women's Open, the LPGA's dream can be seen on the horizon. But Charley Hull must achieve her own dream first. 'It's sad to see': Rising star laments loss of this week's PGA Tour event ...

And what works better by Frank Dobbin and Alexandra Kalev Businesses started caring a lot more about diversity after a series of high-profile lawsuits rocked the financial industry. In the late 1990s ...

HP+AMD: Mastering IT in an era of transformation This guide is your toolkit for turning the demands of today into the opportunities of tomorrow. By aligning strategic vision with advanced technology, ...